Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ebola Vaccines”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02287480
What this trial is testing

VSV-ZEBOV Geneva Vaccine Trial

Who this might be right for
Ebolavirus Disease
University Hospital, Geneva 115
Early research (Phase 1)Study completedNCT02891980
What this trial is testing

A Safety Trial to Test MVA-BN(R)-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers

Who this might be right for
Ebola DiseaseMarburg Disease
National Institute of Allergy and Infectious Diseases (NIAID) 65
Large-scale testing (Phase 3)Study completedNCT04228783
What this trial is testing

2-dose Vaccine Regimen Using 3 Consecutive Lots of Ad26.ZEBOV and MVA-BN-Filo in Adult Participants

Who this might be right for
Ebola
Janssen Vaccines & Prevention B.V. 974
Post-approval studies (Phase 4)Study completedNCT03072030
What this trial is testing

International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi

Who this might be right for
Ebola Virus DiseasePrevention
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 2,000
Early research (Phase 1)Study completedNCT02495246
What this trial is testing

Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV

Who this might be right for
Ebola Virus Disease
University of Oxford 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05909358
What this trial is testing

Solidarity/Tokomeza Ebola Trial

Who this might be right for
Sudan Ebola Virus Vaccines
Makerere University 2,121
Testing effectiveness (Phase 2)Study completedNCT02485301
What this trial is testing

Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults

Who this might be right for
Virus Diseases
GlaxoSmithKline 3,024
Large-scale testing (Phase 3)Ended earlyNCT02661464
What this trial is testing

Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 677
Testing effectiveness (Phase 2)Study completedNCT05130398
What this trial is testing

Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon

Who this might be right for
Ebola Virus Disease
Centre de Recherche Médicale de Lambaréné 120
Early research (Phase 1)Study completedNCT02718469
What this trial is testing

Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults

Who this might be right for
Ebola Virus Disease
Auro Vaccines LLC 38
Large-scale testing (Phase 3)WithdrawnNCT05959421
What this trial is testing

Immunity Induced by VSV-EBOV and Assessment of a Booster Dose in Individuals at Potential Occupational Risk for Exposure

Who this might be right for
Ebola Vaccine
Universitätsklinikum Hamburg-Eppendorf
Early research (Phase 1)Study completedNCT02374385
What this trial is testing

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine

Who this might be right for
Ebola Viruses
Dalhousie University 40
Early research (Phase 1)UnknownNCT02296983
What this trial is testing

Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.

Who this might be right for
Ebola Virus Disease
University of Oxford 40
Early research (Phase 1)Study completedNCT04906629
What this trial is testing

INO-4201 as Booster in Healthy VSV-ZEBOV Vaccinees

Who this might be right for
Ebola Virus Disease
University of Geneva, Switzerland 46
Early research (Phase 1)Study completedNCT00997607
What this trial is testing

Evaluating an Ebola and a Marburg Vaccine in Uganda

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 108
Testing effectiveness (Phase 2)Study completedNCT02564523
What this trial is testing

Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 1,075
Testing effectiveness (Phase 2)Active Not RecruitingNCT06100913
What this trial is testing

Immunology of Ebola Vaccine

Who this might be right for
Ebola Virus Disease
Emory University 30
Testing effectiveness (Phase 2)Study completedNCT03031912
What this trial is testing

African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola

Who this might be right for
Ebola
Canadian Immunization Research Network 251
Early research (Phase 1)Study completedNCT02326194
What this trial is testing

A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults.

Who this might be right for
Ebola Virus Disease
Jiangsu Province Centers for Disease Control and Prevention 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT06803342
What this trial is testing

A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Sudan Ebolavirus Vaccine in Healthy Adults

Who this might be right for
Ebola Sudan Virus Disease
Albert B. Sabin Vaccine Institute 200
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation